About Certis Oncology Solutions
Certis Oncology Solutions is a Healthcare company based in San Diego (United States) founded in 2016 by James H Berglund. Oncology-based in-vivo drug development services are provided. Certis Oncology Solutions has raised $13.65 million across 2 funding rounds. Certis Oncology Solutions offers products and services including CertisAI, Cancer Models, In Vitro Pharmacology, and In Vivo Pharmacology. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Oncology. Its legal entity is CERTIS ONCOLOGY SOLUTIONS, INC.
Company details
Certis Oncology Solutions was founded in 2016 and is based in San Diego, United States. In-vivo services focused on oncology are offered to pharmaceutical and biotechnology companies. Certis Orthotopic PDX techniques, involving patient-derived orthotopic xenografts, are utilized to model human tumor growth, metastasis, and therapy responses. These services support drug development in the oncology sector.
- Total Equity Funding$13.65M (USD)
in 2 rounds
- Latest Funding Round$10M (USD), Series C
Jan 2024
Products & Services of Certis Oncology Solutions
Certis Oncology Solutions offers a comprehensive portfolio of products and services, including CertisAI, Cancer Models, In Vitro Pharmacology, and In Vivo Pharmacology.
AI tool for oncology intelligence and data analysis in research
Custom development of cancer models for testing and pharmacology
Pharmacology testing for drug development in oncology studies
In vivo testing methods for cancer research and endpoint analysis
Apps and channels of Certis Oncology Solutions
its YouTube channel Certis Oncology has 15 subscribers and 24 videos.
Videos from Certis Oncology Solutions
The most watched videos on Certis Oncology Solutions's YouTube channel, Certis Oncology (15 subscribers). Click a video to play it here.
More on Certis Oncology.
Funding Insights of Certis Oncology Solutions
Certis Oncology Solutions has successfully raised a total of $13.65M across 2 strategic funding rounds. The most recent funding activity was a Series C round of $10 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $13.65M
- Total Rounds 2
- Last Round Series C — $10M
- First Round $3.65M
(Nov 2023)
All 2 funding rounds of Certis Oncology Solutions with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2024 | $10M | Series C | – | – | – |
| Nov 2023 | $3.65M | Series A | – | – | – |
People of Certis Oncology Solutions
35 people are tracked at Certis Oncology Solutions (12 in leadership, 14 in board & advisors, 9 in team).
| Name | Role | Group |
|---|---|---|
James H Berglund | Founder & Director | Leadership |
Fernando Eguiarte-Solomon | Director, Study Operations | Leadership |
Rita Dana | Vice President Finance | Leadership |
Howard Kartstein | Senior Director Of Business Development | Leadership |
Peter Ellman | President & CEO | Leadership |
Debbie Snyder-Stanton | VP, Business Development | Leadership |
Brian Datnow | Laboratory Director | Leadership |
Jantzen Sperry | Director, Scientific Operations | Leadership |
Jonathan Nakashima | Chief Scientific Officer | Leadership |
Kristein S. King | Chief Marketing Officer | Leadership |
Raffaella Pippa | Senior Director | Leadership |
Diana Hornberger | Director Of Regulatory And Quality | Leadership |
Stephen Bonner | Director | Board & advisors |
John Tozzi | Director | Board & advisors |
J. Mark Grosvenor | Director | Board & advisors |
Zev A. Wainberg | Medical Advisory Board Member | Board & advisors |
Larry Dickinson | Medical Advisory Board Member | Board & advisors |
Frederick C. Eilber | Director | Board & advisors |
Sandip P. Patel | Medical Advisory Board Member | Board & advisors |
Arun S. Singh | Director | Board & advisors |
15 more people are available in the full profile.
Complete people profiles for Certis Oncology Solutions
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Certis Oncology Solutions
3 dated milestones of Certis Oncology Solutions across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Certis Oncology Solutions is founded.
- Funding First funding round of $3.7M.
- Funding Latest funding round, Series C, of $10.0M.
Web traffic of Certis Oncology Solutions
The website of Certis Oncology Solutions (certisoncology.com) receives about 7.9K visits a month.
- Monthly visits7.9K
▲ 207.6% vs previous month
Websites whose visitors overlap most with Certis Oncology Solutions. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
ithrivebeauty.com | ithrivebeauty.com | 100% | #6,774,498 | – | |
conventusbiomed.com | conventusbiomed.com | 100% | – | ||
| biosettia.com | 100% | 1.3K | #12,690,631 | View details | |
| alfascientific.com | 100% | #8,547,751 | View details | ||
| carihealth.com | 100% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Certis Oncology Solutions
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Certis Oncology Solutions (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Certis Oncology Solutions
Complete news archive for Certis Oncology Solutions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Certis Oncology Solutions
Certis Oncology Solutions was founded in 2016 and raised its 1st funding round 7 years after it was founded.
Certis Oncology Solutions is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Certis Oncology Solutions is a funded company, having raised a total of $13.65M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.65M, raised on Nov 2023.
Certis Oncology Solutions was founded in 2016 and is based in San Diego, United States. In-vivo services focused on oncology are offered to pharmaceutical and biotechnology companies. Certis Orthotopic PDX techniques, involving patient-derived orthotopic xenografts, are utilized to model human tumor growth, metastasis, and therapy responses. These services support drug development in the oncology sector.
Certis Oncology Solutions offers CertisAI, Cancer Models, In Vitro Pharmacology, and In Vivo Pharmacology.
Certis Oncology Solutions operates through Certis Oncology Solutions, Inc..